Overview
A pyrethroid insecticide commonly used in the treatment of lice infestations and scabies. It is a yellow to light orange-brown, low melt-ing solid or viscous liquid.
Background
A pyrethroid insecticide commonly used in the treatment of lice infestations and scabies. It is a yellow to light orange-brown, low melt-ing solid or viscous liquid.
Indication
For the treatment of infestation with Sarcoptes scabiei (scabies).
Associated Conditions
- Head Lice Infestation
- Norwegian scabies
- Scabies
- Lice of the pubic area
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/03/26 | Phase 2 | Not yet recruiting | Children Hospital and Institute of Child Health, Lahore | ||
2024/05/02 | Phase 3 | Completed | |||
2024/04/23 | Phase 3 | Not yet recruiting | Infectopharm Arzneimittel GmbH | ||
2023/05/17 | Phase 1 | Completed | Combined Military Hospital Abbottabad | ||
2023/04/19 | Phase 4 | Completed | |||
2022/12/09 | Phase 1 | Completed | Combined Military Hospital Abbottabad | ||
2022/05/05 | Phase 1 | Completed | Combined Military Hospital Abbottabad | ||
2022/01/20 | Not Applicable | Completed | |||
2021/03/24 | Phase 3 | UNKNOWN | Infectopharm Arzneimittel GmbH | ||
2020/04/02 | Phase 2 | Recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Actavis Pharma, Inc. | 0472-0242 | TOPICAL | 50 mg in 1 g | 12/31/2019 | |
| Rebel Distributors Corp | 21695-907 | TOPICAL | 50 mg in 1 g | 1/5/2007 | |
| NuCare Pharmaceuticals,Inc. | 68071-3316 | TOPICAL | 50 mg in 1 g | 2/12/2021 | |
| NuCare Pharmaceuticals,Inc. | 68071-1627 | TOPICAL | 50 mg in 1 g | 1/28/2022 | |
| Physicians Total Care, Inc. | 54868-5391 | TOPICAL | 50 mg in 1 g | 6/1/2012 | |
| Northstar Rx LLC | 16714-897 | TOPICAL | 50 mg in 1 g | 4/8/2019 | |
| Preferred Pharmaceuticals Inc. | 68788-8439 | TOPICAL | 50 mg in 1 g | 6/5/2023 | |
| H.J. Harkins Company, Inc. | 52959-159 | TOPICAL | 50 mg in 1 g | 2/10/2012 | |
| Padagis Israel Pharmaceuticals Ltd | 45802-269 | TOPICAL | 50 mg in 1 g | 1/10/2017 | |
| Central Texas Community Health Centers | 76413-159 | TOPICAL | 50 mg in 1 g | 3/1/2018 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| LYCLEAR SCABIES CREAM | 46343 | Medicine | A | 9/7/1993 |